다운스트림 공정 시장 규모, 점유율, 성장 분석 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Downstream Processing Market Size, Share, and Growth Analysis, By Technique (Purification, Solid-liquid Separation), By Product (Chromatography Columns and Resins, Filters), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1663861
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
다운스트림 공정 시장 규모는 2023년 364억 달러로 평가되며, 예측 기간(2025-2032년) 동안 16.4%의 CAGR로 2024년 423억 7,000만 달러에서 2032년 1,427억 8,000만 달러로 성장할 것으로 예상됩니다.
세계 다운스트림 공정 시장은 바이오의약품 및 바이오테크놀러지 제품에 대한 수요 증가에 힘입어 큰 폭의 성장세를 보이고 있습니다. 바이오의약품의 효율적인 정제 및 생산 기술을 찾는 기업이 늘어남에 따라 다운스트림 공정 기술은 필수 불가결한 요소가 되고 있습니다. 머크가 우시 국가첨단 기술산업개발구와 맺은 협력 관계는 용량 확대에 대한 업계의 의지를 보여줍니다. 그러나 높은 설비 비용과 막대한 초기 투자비용은 특히 중소기업의 성장에 걸림돌이 될 수 있습니다. 크로마토그래피와 여과의 발전은 효율성과 확장성을 향상시키고, 일회용 기술로의 전환은 공정을 간소화하고, 오염 위험을 최소화하며, 생산 일정을 앞당기고 있습니다. 바이오 제약 부문이 계속 성장함에 따라 혁신적인 시장 상황이 예상되며, 혁신적인 솔루션에 대한 수요가 급증할 것으로 예상됩니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 가정과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
시장 생태계
시장 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
다운스트림 공정 시장 규모 : 기술별 & CAGR(2025-2032년)
시장 개요
정제
고체-액체 분리
정화/농축
다운스트림 공정 시장 규모 : 제품별 & CAGR(2025-2032년)
시장 개요
크로마토그래피 컬럼과 수지
필터
멤브레인 흡착제
일회용 제품
기타 제품
소모품
액세서리
다운스트림 공정 시장 규모 : 용도별 & CAGR(2025-2032년)
시장 개요
단클론항체 생산
백신 제조
인슐린 생산
면역글로불린 생산
에리스로포이에틴 생산
기타 용도
인터페론
융합 단백질
성장호르몬
혈액응고인자
항응고제
의료용 효소
항균
항생제
집락자극인자
다운스트림 공정 시장 규모 : 최종사용자별 & CAGR(2025-2032년)
시장 개요
바이오의약품 제조업체
계약 제조 조직(CMO)
다운스트림 공정 시장 규모 : 지역별 & CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
최근의 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년비 비교(2022-2024년)
주요 기업 개요
Thermo Fisher Scientific Inc.(U.S.)
Merck KGaA(MilliporeSigma)(Germany)
Danaher Corporation(Cytiva)(U.S.)
Sartorius Stedim Biotech S.A.(France)
Lonza Group AG(Switzerland)
3M Company(U.S.)
Boehringer Ingelheim International GmbH(Germany)
Eppendorf AG(Germany)
Repligen Corporation(U.S.)
GE Healthcare(U.S.)
Corning Incorporated(U.S.)
Dover Corporation(U.S.)
Asahi Kasei(Japan)
Pall Corporation(U.S.)
Bio-Rad Laboratories, Inc.(U.S.)
Agilent Technologies Inc.(U.S.)
Finesse Solutions, Inc.(U.S.)
Novasep(France)
Rentschler Biopharma(Germany)
Vetter Pharma International GmbH(Germany)
결론과 제안
ksm
영문 목차
영문목차
Downstream Processing Market size was valued at USD 36.4 billion in 2023 and is poised to grow from USD 42.37 billion in 2024 to USD 142.78 billion by 2032, growing at a CAGR of 16.4% during the forecast period (2025-2032).
The Global Downstream Processing Market is set for significant growth driven by the rising demand for biopharmaceuticals and biotechnology products. As companies increasingly seek efficient purification and production techniques for biotherapeutics, downstream processing technologies become essential. Collaborations like Merck's agreement with Wuxi National High-tech Industrial Development Zone illustrate the industry's commitment to expanding capabilities. However, challenges such as high equipment costs and substantial initial investments may hinder growth, particularly for smaller firms. Advancements in chromatography and filtration are improving efficiency and scalability, while the shift toward single-use technologies is streamlining processes, minimizing contamination risks, and accelerating production timelines. As the biopharmaceutical sector continues to thrive, the demand for innovative downstream processing solutions will likely surge, promising a dynamic market landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Downstream Processing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Downstream Processing Market Segments Analysis
Global Downstream Processing Market is segmented by Technique, Product, Application, End User and region. Based on Technique, the market is segmented into Purification, Solid-liquid Separation and Clarification/Concentration. Based on Product, the market is segmented intoChromatographyColumns and Resins, Filters, Membrane Adsorbers, Single-use Products and Other Products. Based on Application, the market is segmented into Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production and Other Applications. Based on End User, the market is segmented into Biopharmaceutical Manufacturers and Contract Manufacturing Organizations (CMOs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Downstream Processing Market
The increasing need for biopharmaceuticals, including monoclonal antibodies, vaccines, and recombinant proteins, is driving growth in the downstream processing market. This sector is essential for the purification and isolation of these intricate biological products, which is vital for ensuring their safety and effectiveness. As the biopharmaceutical industry continues to expand, there is a corresponding surge in the demand for advanced downstream processing technologies and equipment. This trend highlights the critical role that downstream processing plays in the overall biopharmaceutical production pipeline, thereby making it a key driver for market development and innovation in the industry.
Restraints in the Downstream Processing Market
The Downstream Processing market faces various restraints due to the unique attributes of each biopharmaceutical product, including size, charge, solubility, and stability. These distinct characteristics can lead to complications such as low yields, challenging purification processes, and a heightened risk of degradation throughout purification stages. As a result, creating customized downstream processes for diverse products, while simultaneously tackling product-specific obstacles, can be quite intricate. This complexity necessitates a high level of expertise and considerable optimization efforts, ultimately making it a significant challenge for companies operating within this field to achieve efficient and effective processing solutions.
Market Trends of the Downstream Processing Market
The downstream processing market is witnessing a significant trend towards process intensification and continuous manufacturing methodologies, driven by the need for enhanced efficiency and productivity in biopharmaceutical production. Techniques such as continuous chromatography and continuous centrifugation are becoming increasingly popular, offering benefits like real-time monitoring and improved process control. These innovations facilitate the optimization of processing operations, resulting in higher yields and reduced processing times. As companies strive to shorten production timelines and minimize costs, the adoption of these advanced technologies is poised to reshape the downstream processing landscape, underscoring the industry's commitment to continuous improvement and operational excellence.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Downstream Processing Market Size by Technique & CAGR (2025-2032)
Market Overview
Purification
Solid-liquid Separation
Clarification/Concentration
Global Downstream Processing Market Size by Product & CAGR (2025-2032)
Market Overview
Chromatography Columns and Resins
Filters
Membrane Adsorbers
Single-use Products
Other Products
Consumables an
Accessories
Global Downstream Processing Market Size by Application & CAGR (2025-2032)
Market Overview
Monoclonal Antibody Production
Vaccine Production
Insulin Production
Immunoglobulin Production
Erythropoietin Production
Other Applications
Interferons
Fusion Proteins
Growth Hormones
Blood Coagulation Factors
Anticoagulants
Medical Enzymes
Anti-bacterial
Antibiotics
Colony Stimulating Factors
Global Downstream Processing Market Size by End User & CAGR (2025-2032)
Market Overview
Biopharmaceutical Manufacturers
Contract Manufacturing Organizations (CMOs)
Global Downstream Processing Market Size & CAGR (2025-2032)
North America (Technique, Product, Application, End User)
US
Canada
Europe (Technique, Product, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Technique, Product, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Technique, Product, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Technique, Product, Application, End User)
